The global Respiratory Active Pharmaceutical Ingredients (API) market was valued at approximately USD 18.2 billion in 2023 and is projected to reach around USD 30.5 billion by 2031, growing at a compound annual growth rate (CAGR) of about 6.7% during the forecast period from 2024 to 2031. The comprehensive use of integrated methodologies yields a wonderful Respiratory Active Pharmaceutical...